Saturday, September 26, 2026RSS
Peptide.Wire

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

Researchsemaglutideglp-1inflammationmitochondria

Semaglutide shifts human macrophages away from M1 phenotype via cAMP

In THP-1 and U-937 cell lines, 100 nM semaglutide raised SIRT1, PGC-1alpha and mtDNA/nDNA ratios, effects blocked by an adenylyl cyclase inhibitor.

PR
By Priya Raman · Science Reporter
Sep 2 20:00 ETSource: Biomedicines

The wire

  1. 01Semaglutide at 100 nM cut CD80/CD86, TNF-alpha and IL-6 while raising CD206, CD163 and IL-10 in LPS/IFN-gamma polarized macrophages from two monocytic cell lines.
  2. 02The work offers a direct anti-inflammatory mechanism for a GLP-1 agonist beyond weight loss, tied to GLP-1R and cAMP signaling and markers of mitochondrial biogenesis.
  3. 03Findings come from immortalized cell lines only, with no animal or human confirmation, and mitochondrial biogenesis was inferred from ratio markers rather than measured function.

From the source

Semaglutide Attenuates Inflammatory Macrophage Polarization and Promotes Changes Associated with Mitochondrial Biogenesis Through cAMP-Dependent Signaling

Biomedicines · 2026 Sep 3 · Pavshintsev VV, Erbaeva AZ, Vatlin AA et al.

Read at pubmed.ncbi.nlm.nih.gov
PeptiPrescribed peptides from $99/moSee all →